Eur Rev Med Pharmacol Sci 2021; 25 (20): 6408-6410
DOI: 10.26355/eurrev_202110_27014

Commentary: registered adverse events following COVID-19 immunization in Serbia

D. Živanović, V.M. Jovin, J. Javorac, M. Ilić, P. Zelić

Department of Biomedical Sciences, College of Vocational Studies for the Education of Preschool Teachers and Sports Trainers, Subotica, Serbia. dejanzivanovic@vsovsu.rs

Free PDF Download

To cite this article

D. Živanović, V.M. Jovin, J. Javorac, M. Ilić, P. Zelić
Commentary: registered adverse events following COVID-19 immunization in Serbia

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6408-6410
DOI: 10.26355/eurrev_202110_27014

Publication History

Published online: 27 Oct 2021

Keywords Related articles:

  1. Commentary: are blood and saliva sources of COVID-19 spread?
  2. Commentary: Tele-COVID-19: does it improve the provision of health services?
  3. Commentary – CRISPR-based techniques: Cas9, Cas13 and their applications in the era of COVID-19
  4. Impact of COVID-19 on otolaryngology in Italy: a commentary from the COVID-19 task force of the Young Otolaryngologists of the Italian Society of Otolaryngology
  5. Infliximab in inflammatory bowel disease: attention to adverse events